ArticleStem cell research & therapy2022

Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients.

Elena Atanasova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.